FDA Authorizes Emergency Use Of Johnson & Johnson's Single-dose COVID-19 Vaccine

The U.S. Food and Drug Administration on Saturday authorized Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine for emergency use.

It is the first single-shot COVID-19 vaccine and the third COVID-19 vaccine for emergency use in the U.S. - the other two being Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273.

Subscribe to continue reading the article.

This article is part of our premium content offering.Subscribe with a RTTNews subscription.

Already subscribed? Sign in

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com